1-12 of 12
Keywords: Cyclosporin A
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal: Dermatology
Dermatologica (1985) 171 (2): 65–71.
Published Online: 13 October 2009
...K. Al Rustom; C. Pierard-Franchimont; G.E. Pierard Evaluation of the clinical and histological signs of cutaneous graft-versus-host disease present in 7 patients treated with cyclosporin A was based on a follow-up of 100 days after bone marrow transplantation. Early clinical signs consisted...
Journal Articles
Journal: Dermatology
Dermatology (1993) 186 (1): 62–67.
Published Online: 08 October 2009
...S.A. Wagner; R.U. Peter; O. Adam; T. Ruzicka Six male patients with severe psoriatic arthritis (PA) unresponsive to various topical and systemic therapies have been treated with oral cyclosporin A (CyA; Sandimmun®) solution at daily doses ranging usually from 1.5 to 5.0 mg/kg. In 1 case the dose...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (1995) 190 (3): 192–196.
Published Online: 07 October 2009
...-glycoprotein (Pgp). Cyclosporin A (CSA) is a potent inhibitor of Pgp. Methods and Results : Efficacy of CSA was tested in its effects on chemotherapy-induced alopecia in the newborn rat animal model. CSA, when applied topically, protected rats from local alopecia induced by various agents. Conclusion...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (1997) 195 (1): 91–92.
Published Online: 06 October 2009
...M.C. Aebischer; L.B. Zala; L.R. Braathen We report 2 patients, negative for human immunodeficiency virus (HIV) antibodies, who developed generalized Kaposi’s sarcoma (KS), one 5 months after renal transplantation while receiving cyclosporin A and prednisone, and the other 24 months after heart...
Journal Articles
Journal: Dermatology
Dermatology (2003) 206 (2): 153–156.
Published Online: 10 March 2003
...S.P. Cannavò; F. Guarneri; M. Vaccaro; F. Borgia; B. Guarneri Background: Nail involvement is a frequent event in the course of psoriasis causing severe distress. While systemic cyclosporin (CsA) represents a well-established therapy of psoriasis, its topical use is limited by the difficult...
Journal Articles
Journal: Dermatology
Dermatology (2000) 200 (4): 324–327.
Published Online: 06 July 2000
...Kazunari Usuki; Mitsuhiro Sekiyama; Tokihiko Shimada; Shoko Shimada; Tamotsu Kanzaki Background: Pityriasis rubra pilaris (PRP) is reported to respond poorly to cyclosporin A (CsA). Objective: We attempted to determine the efficacy of CsA in the treatment of classic adult-type PRP. Methods: Three...
Journal Articles
Journal: Dermatology
Dermatology (1999) 199 (2): 144–148.
Published Online: 22 October 1999
... with psoriasis, not responding to local treatment and to study the effect of cyclosporin A (CsA) on these markers. Methods: Twenty-seven patients and 30 healthy controls were included in the study. The results were evaluated at baseline and at 15 days, 3, 6 and 12 months following initiation of treatment...
Journal Articles
Journal: Dermatology
Dermatology (1999) 198 (2): 198–202.
Published Online: 26 April 1999
... and thalidomide, but without any clear-cut outcome. Cyclosporin A (CsA) has many inhibitory effects on the main cell populations involved in TEN (T lymphocytes, macrophages and keratinocytes). CsA could also act on tumor necrosis factor α metabolism, a cytokine which is important in TEN epidermal destruction...
Journal Articles
Journal: Dermatology
Dermatology (1998) 196 (4): 450–452.
Published Online: 26 June 1998
...P. Paquet; G.E. Piérard We report malignant neoplasms of the breast and lung developed in two psoriatic patients after long-term treatment with low-dose cyclosporin A (CsA). A procarcinogen role of the drug cannot be ignored. Concern regarding the documented evidence from studies of organ...
Journal Articles